Research review
Is milk thistle anti-inflammatory? What the research does and doesn't show
The evidence on milk thistle and inflammation is mixed and condition-specific. A 2024 pooled analysis in a general cardiometabolic population found no significant change in C-reactive protein, while smaller trials in diabetic kidney disease and pre-heart-surgery patients found inflammatory markers came out lower with silymarin.
The evidence on milk thistle and inflammation is mixed and specific to who was studied. In the largest pooled analysis, run mostly in people with a metabolic condition, C-reactive protein didn't change significantly with silymarin. In two smaller, more specific trials — one in diabetic kidney disease, one in people about to have heart surgery — inflammatory markers were lower with silymarin than without it.
What the evidence doesn't support
It doesn't support milk thistle or silymarin as a general anti-inflammatory treatment, and it doesn't support using it for arthritis, chronic pain, gout or any other diagnosed inflammatory condition — none of those were tested in the research reviewed here. The largest pooled trial data available found no significant change in C-reactive protein, the most commonly used general inflammation marker. Nothing here describes a specific product's dose, and nothing here is a claim about any product.
What the trials found
A 2024 systematic review and dose-response meta-analysis pooled 33 controlled trials (1,943 participants) on silymarin's effect on cardiovascular and metabolic risk factors, including C-reactive protein (CRP), a standard blood marker of inflammation. Across the pooled trials, CRP did not differ significantly between silymarin and placebo or control groups — a null result on the field's broadest general marker, in a population concentrated in people with diabetes, fatty liver disease or another metabolic condition.
Two smaller, more specific trials found different results. A 2012 trial in 60 people with type 2 diabetes and diabetic kidney disease gave 420 mg/day of silymarin for three months and found urinary TNF-alpha, an inflammatory cytokine, and markers of oxidative stress were significantly lower with silymarin than placebo, alongside a larger drop in a urine-protein marker of kidney damage. And in the 2024 coronary bypass surgery study covered in more depth on our milk thistle and heart disease page, patients given 400 mg of silymarin before surgery had significantly lower C-reactive protein measured after surgery than those who weren't given it, alongside fewer cases of postoperative atrial fibrillation. That study didn't state it was randomized or blinded.
Taken together, the pattern in this specific literature is that a general, healthy-population inflammation marker (CRP, pooled across a broad cardiometabolic group) didn't move, while narrower markers in two specific clinical populations — diabetic kidney disease and pre-heart-surgery patients — did. That's not the same as milk thistle being "anti-inflammatory" as a general property; it's three separate results in three separate, non-healthy populations.
| Trial | Population | Inflammation marker | Result |
|---|---|---|---|
| Mohammadi 2024 (33 pooled trials, n=1,943) | Adults with cardiometabolic risk factors | CRP | No significant difference vs. control |
| Fallahzadeh 2012 (n=60) | Type 2 diabetes with diabetic nephropathy | Urinary TNF-alpha | Lower with silymarin vs. placebo |
| Okiljevic 2024 (n=160) | Adults before coronary bypass surgery | Postoperative CRP | Lower with silymarin vs. no-silymarin group |
Questions people ask
Is milk thistle anti-inflammatory?
The evidence is mixed. The largest pooled analysis found no significant change in C-reactive protein, a standard general inflammation marker. Two smaller trials in specific populations — diabetic kidney disease and pre-heart-surgery patients — found inflammatory markers came out lower with silymarin, but neither tested a healthy general population.
Is milk thistle good for liver inflammation?
That's a separate, more studied question — see milk thistle, fatty liver, cirrhosis and hepatitis for the liver-enzyme and histology findings specifically.
Is milk thistle good for gout?
No trial we found tested milk thistle for gout specifically. It isn't part of the research reviewed here.
When to talk to a doctor
Anyone with a diagnosed inflammatory or autoimmune condition should manage it with a doctor's guidance; milk thistle is not a treatment for arthritis, gout or any other inflammatory disease, and the research above doesn't support using it as one. If you take a prescription medication, ask a doctor before adding milk thistle — see milk thistle and medications: what to check.
Related reading: milk thistle and heart disease, milk thistle benefits: what the research does and doesn't show, and milk thistle and diabetes.
Sources
- Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose-Response Meta-Analysis A 2024 pooled analysis of 33 trials (1,943 people) found silymarin significantly lowered total cholesterol, triglycerides and LDL compared with control, with no significant change in HDL, body weight or BMI — and the authors say the findings need confirming in larger, longer trials.
- Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial A small 2012 trial in people with diabetic kidney disease found 420 mg/day of silymarin for 3 months reduced a urine-protein marker more than placebo, alongside lower inflammation and oxidative-stress markers.
- The Effect of Silymarin on the Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting A 2024 controlled study in 160 people undergoing coronary bypass surgery found fewer developed atrial fibrillation after surgery when given 400 mg of silymarin beforehand versus a group that didn't receive it, though the study doesn't state it was randomized or blinded.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.